目的：分析无晶状体患者虹膜夹型人工晶状体(ICIOL)与巩膜固定型人工晶状体(SFIOL)在视力、手术时间及术后并发症方面的疗效。方法：前瞻性研究。共纳入2018-10/2020-02在我院门诊就诊的60例60眼无晶状体眼患者。将所有患者分为两组，每组各30例。组I患者行ICIOL植入术，组II患者行SFIOL植入术。筛除既往有眼部病变和视网膜手术史患者。术前、术后随访9mo。结果：随访9mo后，ICIOL组中26例(87%)患者，SFIOL组中24例(80%)患者达到最佳矫正视力(BCVA，LogMAR)为0.50～0.00。两组BCVA 均值具有可比性。 ICIOL组手术时间较SFIOL组更短(P<0.01)。SFIOL组并发症明显增多，而ICIOL组的并发症较少。结论：两组的视觉结果具有可比性。在无晶状体矫正中，ICIOL并发症少，手术时间短，是较SFIOL更好的手术方式。

AIM: To analyze the efficacy of iris-claw intraocular lens(ICIOL)and scleral-fixator intraocular lens(SFIOL)in terms of visual outcomes, surgical time, and postoperative complications in the aphakic patients.METHODS: This study was a prospective study with 60 aphakic eyes of 60 patients who attended our outpatient department from October 2018 to February 2020. These patients were divided into two groups and each with 30 patients. Patients in Group I were underwent ICIOL whereas patients in Group II underwent SFIOL implantation. Patients with pre-existing ocular pathologies, previous history of retinal surgery of the eye were excluded. The preoperative and postoperative evaluation was done for the follow up period of 9mo.RESULTS: Twenty-six(87%)patients in the ICIOL group and 24(80%)patients in SFIOL group had best corrected visual acuity(BCVA,LogMAR)with 0.50-0.00 after 9mo follow up. The mean of BCVA(LogMAR)was comparable in both the groups. The surgical time in ICIOL was significantly less than the SFIOL group(P<0.01). Complications related to sutures were significantly more in the SFIOL group. Complications found in the ICIOL group were very mild and harmless. CONCLUSION: The visual outcome was comparable in both groups. ICIOL with fewer complications and requiring less surgical time was found to be a better alternative to SFIOL in the correction of aphakia.